SIA LearnBetter rates each claimed use from Proven to Failed and lists legal status in ten regions, in six languages. It says entries haven't yet been reviewed by a clinician.
Recap by typeshit. Full story at Yahoo Finance.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
The Kann owner says the drug quieted his late-night and stress eating but not his love of big flavor, and argues restaurants should rethink portion size.
Farm Progress links rising beef demand to GLP-1 users, an unexpected ripple from the weight loss drug boom into agriculture.
Loading…